28 related articles for article (PubMed ID: 1672520)
1. Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state.
Myint O; Wattanapongpitak S; Kothan S; Udomtanakunchai C; Tima S; Tungjai M
Toxicol Rep; 2022; 9():1443-1451. PubMed ID: 36518452
[TBL] [Abstract][Full Text] [Related]
2. Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.
Bogorad MI; Searson PC
Integr Biol (Camb); 2016 Sep; 8(9):976-84. PubMed ID: 27523481
[TBL] [Abstract][Full Text] [Related]
3. Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.
Reungpatthanaphong P; Marbeuf-Gueye C; Le Moyec L; Salerno M; Garnier-Suillerot A
J Bioenerg Biomembr; 2004 Dec; 36(6):533-43. PubMed ID: 15692732
[TBL] [Abstract][Full Text] [Related]
4. Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.
Tarasiuk J; Stefańska B; Plodzich I; Tkaczyk-Gobis K; Seksek O; Martelli S; Garnier-Suillerot A; Borowski E
Br J Pharmacol; 2002 Mar; 135(6):1513-23. PubMed ID: 11906965
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of doxorubicin handling by isolated hepatocytes is a valuable indicator for restored cell function.
Crivellato E; Donini A; Baccarani U; Lavaroni S; Candussio L; Degrassi A; Bresadola F
Histochem J; 2000 Sep; 32(9):535-43. PubMed ID: 11127974
[TBL] [Abstract][Full Text] [Related]
6. The accumulation and compartmentalization of isometamidium chloride in Trypanosoma congolense, monitored by its intrinsic fluorescence.
Wilkes JM; Peregrine AS; Zilberstein D
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):319-27. PubMed ID: 7492332
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II in multiple drug resistance.
Hofmann GA; Mattern MR
Cytotechnology; 1993; 12(1-3):137-54. PubMed ID: 7765323
[TBL] [Abstract][Full Text] [Related]
9. Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells.
Tarasiuk J; Garnier-Suillerot A
Eur J Biochem; 1992 Mar; 204(2):693-8. PubMed ID: 1541282
[TBL] [Abstract][Full Text] [Related]
10. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
Borrel MN; Pereira E; Fiallo M; Garnier-Suillerot A
Eur J Biochem; 1994 Jul; 223(1):125-33. PubMed ID: 7518390
[TBL] [Abstract][Full Text] [Related]
11. DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives.
Frezard F; Garnier-Suillerot A
Biochemistry; 1991 May; 30(20):5038-43. PubMed ID: 2036371
[TBL] [Abstract][Full Text] [Related]
12. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells.
Wielinga PR; Westerhoff HV; Lankelma J
Eur J Biochem; 2000 Feb; 267(3):649-57. PubMed ID: 10651800
[TBL] [Abstract][Full Text] [Related]
13. Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.
Pereira E; Borrel MN; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1994 Jan; 1225(2):209-16. PubMed ID: 7904185
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells.
Frezard F; Garnier-Suillerot A
Eur J Biochem; 1991 Mar; 196(2):483-91. PubMed ID: 1672520
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
